H2
Health 2047 Capital Partners focuses on transforming the U.S. healthcare system by investing in technology or technology-enabled services and solutions across the health industry. The firm is stage-agnostic but typically invests in Series A and beyond, targeting companies that address radical productivity, healthcare value, chronic disease, and data liquidity, often leveraging insights from its anchor partner, the American Medical Association.
100% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Average disclosed round size is $41.0M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series C
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nest Health | Series A | $12.5M | Oct 2025 |
 Harbor Health | Series C | $95.5M | Jan 2024 |
 Bayesian Health | Unknown | $15M | Jul 2021 |
Top Co-Investors
8VC2 shared
General Catalyst1 shared
Alta Partners1 shared
Lemhi Ventures1 shared
Martin Ventures1 shared
Blue Venture Fund1 shared
Amboy Street Ventures1 shared
Alumni Ventures Group1 shared
Andreessen Horowitz1 shared
Lifeforce Capital1 shared
Catalio Capital Management1 shared
Last updated: 16 April 2026